(331) Solid Organ Transplantation Improves Sexual Dysfunction In Older Men And Women

L Thompson,T Yatsenko,C Riveros,A Muthigi

DOI: https://doi.org/10.1093/jsxmed/qdae167.319

2024-12-12

The Journal of Sexual Medicine

Abstract:Introduction Solid organ transplant recipients experience life-prolonging benefits. While a substantial body of literature addresses the fertility consequences of transplantation, data on the post-transplant sexual function in both male and female recipients is relatively sparse. This study aims to evaluate sexual dysfunction and fertility issues in this patient population and contribute to the existing body of knowledge regarding the long-term quality of life of transplant recipients. Objective The primary objective is to assess the prevalence and extent of sexual dysfunction among patients who have undergone solid organ transplantation. This includes various types of sexual dysfunction such as erectile dysfunction, vaginismus, dyspareunia, and other related conditions. Another key objective is to investigate fertility issues in both male and female transplant recipients. Methods This study utilized the TriNetX Global Collaborative Network, a federated database containing >140 million anonymized electronic medical records participating healthcare organizations around the world. Using International Classification of Diseases (ICD) codes, adult patients (≥18 years old) who had undergone solid organ (heart, kidney, liver, lung, and pancreas) transplantation were selected. The primary outcome was a composite of sexual dysfunction, including erectile dysfunction, ejaculatory dysfunction, vaginismus, dyspareunia, orgasmic disorder, hypoactive sexual desire disorder, decreased libido, sexual dysfunction not attributable to substance use or a known physiological condition, and vulvar/vaginal atrophy. The secondary outcome was a composite of male/female infertility as defined by ICD codes. Outcomes were defined a priori and reported as absolute risk reduction (ARR), risk ratios (RR) with 95% confidence intervals (CI). The index event was the date of the transplant, and significance was set at P < 0.05. Results A total of 81,341 solid organ transplant recipients were identified. The mean age at transplant was 52 ± 14.2 years, 39% of patients were female, 20% were Black, 11% were Hispanic, and 4% were Asian. Mean follow up was 6 years. Most common comorbidities included hypertension (59%), diabetes mellitus (38%), obesity (21%), and depression (21%). Following solid organ transplant, the ARR of sexual dysfunction was 12.5%, with a RR of 0.83, 95% CI 0.79-0.86, P < 0.001. The ARR for infertility after solid organ transplantation was 0.048%, with a RR of 0.86, 95% CI 0.73-1.02, P = 0.09. Conclusions This large-scale study highlights significant improvements in sexual health for solid organ transplant recipients, with a significant ARR in sexual dysfunction. Although a reduction in infertility risk was observed, it was not statistically significant. These findings emphasize the importance of considering sexual health in post-transplant care and suggest a need for further research to better understand and address fertility issues in this population. Disclosure No.

urology & nephrology